Klaus Bendtzen
#112,299
Most Influential Person Now
Klaus Bendtzen's AcademicInfluence.com Rankings
Klaus Bendtzenbiology Degrees
Biology
#6281
World Rank
#8959
Historical Rank
Immunology
#318
World Rank
#331
Historical Rank

Download Badge
Biology
Klaus Bendtzen's Degrees
- PhD Medical Science University of Copenhagen
- Doctorate Medicine University of Copenhagen
Why Is Klaus Bendtzen Influential?
(Suggest an Edit or Addition)Klaus Bendtzen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. (1986) (580)
- Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (1999) (476)
- Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab. (2006) (427)
- Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial (2013) (416)
- Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis (2008) (397)
- Prognostic laboratory markers of joint damage in rheumatoid arthritis (2004) (396)
- Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. (1991) (357)
- Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis (2003) (354)
- Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. (1994) (321)
- Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. (1987) (307)
- Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. (1988) (262)
- Extraintestinal manifestations of inflammatory bowel disease: Epidemiology, diagnosis, and management (2010) (257)
- Autoantibodies to cytokines--friends or foes? (1990) (221)
- Immunogenicity of interferon‐β in multiple sclerosis patients: Influence of preparation, dosage, dose frequency, and route of administration (2000) (214)
- Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies. (2007) (211)
- Appearance and disappearance of neutralizing antibodies during interferon-beta therapy (2005) (198)
- 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. (1992) (195)
- Cytokines Cause Functional and Structural Damage to Isolated Islets of Langerhans (1985) (195)
- Immunohistological detection of interleukin 1‐like molecules and tumour necrosis factor in human epidermis before and after UVB‐irradiation in vivo (1988) (191)
- T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis (2008) (187)
- Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease (2011) (175)
- Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case–control study nested in a cohort of Norwegian blood donors (2007) (166)
- Serum concentrations of the interferon-γ-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease (2002) (160)
- Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies (2009) (156)
- Association between HLA‐DR2 and Production of Tumour Necrosis Factor α and Interleukin 1 by Mononuclear Cells Activated by Lipopolysaccharide (1988) (155)
- Tumor Necrosis Factor-Alpha Binding Capacity and Anti-Infliximab Antibodies Measured by Fluid-Phase Radioimmunoassays as Predictors of Clinical Efficacy of Infliximab in Crohn's Disease (2008) (155)
- Mediators of immunity: lymphokines and monokines. (1980) (155)
- Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis (1993) (155)
- Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease (2011) (148)
- Periodontal and hematological characteristics associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. (2006) (147)
- Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro. (1990) (142)
- Affinity-purified human Interleukin I is cytotoxic to isolated islets of Langerhans (2006) (141)
- Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease: Post Hoc Analysis of a Randomized Controlled Trial (2014) (129)
- Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations. (1998) (128)
- Binding of cytokines to pharmaceutically prepared human immunoglobulin. (1993) (128)
- Modulation of Natural Killer Cell Activity in Peripheral Blood by Physical Exercise (1988) (128)
- High-avidity autoantibodies to cytokines. (1998) (123)
- Marginal periodontitis and cytokines: a review of the literature. (1993) (123)
- Inhibition of production and function of interleukin-6 by 1,25-dihydroxyvitamin D3. (1991) (122)
- Interleukin 6 primes human neutrophil and monocyte oxidative burst response. (1989) (122)
- Cytokines in sputum and serum from patients with cystic fibrosis and chronic pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs. (1993) (121)
- Auto‐Antibodies to Tumour Necrosis Factor a in Healthy Humans and Patients with Inflammatory Diseases and Gram‐Negative Bacterial Infections (1989) (117)
- Anti‐Interleukin‐6 Antibodies in Normal Human Serum (1991) (115)
- Low concentrations of interleukin-1 stimulate and high concentrations inhibit insulin release from isolated rat islets of Langerhans. (1986) (115)
- Validity of histopathological grading of articular cartilage from osteoarthritic knee joints (1999) (114)
- Interferons and interferon (IFN)‐inducible protein 10 during highly active anti‐retroviral therapy (HAART)—possible immunosuppressive role of IFN‐α in HIV infection (2000) (112)
- Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease (2013) (112)
- Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function. (1989) (109)
- Immune hormones (cytokines); pathogenic role in autoimmune rheumatic and endocrine diseases. (1989) (109)
- Immunogenicity of interferon-beta in multiple sclerosis patients: influence of preparation, dosage, dose frequency, and route of administration. Danish Multiple Sclerosis Study Group. (2000) (107)
- 1,25-Dihydroxyvitamin D3 as a natural regulator of human immune functions. (1996) (106)
- Clinical implications of variations in anti‐infliximab antibody levels in patients with inflammatory bowel disease (2012) (105)
- Serum levels of the interferon-γ-inducing cytokine interleukin-18 are increased in individuals at high risk of developing Type I diabetes (2001) (103)
- Effect of physical exercise on in vitro production of interleukin 1, interleukin 6, tumour necrosis factor-α, interleukin 2 and interferon-γ (1991) (103)
- Cytokine profiles in peripheral blood and whole blood cell cultures associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. (2005) (101)
- Inhibition of PTH secretion by interleukin-1 beta in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium-sensing receptor mRNA. (1997) (101)
- Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFα antagonists. (2011) (96)
- Antibodies Against Infliximab Are Associated with De Novo Development of Antibodies to Adalimumab and Therapeutic Failure in Infliximab-to-Adalimumab Switchers with IBD (2014) (95)
- Increased serum levels of interleukin-18 in patients with multiple sclerosis (2001) (94)
- Murine concanavalin A–induced hepatitis is prevented by interleukin 12 (IL‐12) antibody and exacerbated by exogenous IL‐12 through an interferon‐γ–dependent mechanism (2000) (93)
- Cytokine expression in labial salivary glands from patients with primary Sjögren's syndrome. (1992) (92)
- Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies (2020) (90)
- Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies (2016) (90)
- Histologic/histochemical grading system for osteoarthritic articular cartilage: reproducibility and validity. (1997) (88)
- Cytokines and natural regulators of cytokines. (1994) (87)
- 1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro. (1993) (87)
- IgG Autoantibodies against Interleukin 1α in Sera of Normal Individuals (1989) (86)
- Interleukin-13 prevents autoimmune diabetes in NOD mice. (1999) (86)
- Islet Cytotoxicity of Interleukin 1: Influence of Culture Conditions and Islet Donor Characteristics (1987) (86)
- mTOR as a multifunctional therapeutic target in HIV infection. (2011) (86)
- High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG. (1995) (85)
- Ultrastructural studies of time-course and cellular specificity of interleukin-1 mediated islet cytotoxicity. (2009) (85)
- Blood cell gene expression profiling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor. (2004) (85)
- Mechanisms of Pancreatic Islet Cell Destruction Dose‐Dependent Cytotoxic Effect of Soluble Blood Mononuclear Cell Mediators on Isolated Islets of Langerhans (1986) (83)
- Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn’s Disease Patients Failing Infliximab (2015) (83)
- Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I. (1993) (82)
- Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay. (1991) (81)
- Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile chronic arthritis. (1998) (80)
- Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review. (1994) (79)
- Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45R0+ cells. (1992) (78)
- Prevention of endotoxin‐induced lethality in neonatal mice by interleukin‐13 (1997) (78)
- Polymorphisms within the IL-1 gene cluster: effects on cytokine profiles in peripheral blood and whole blood cell cultures of patients with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. (2007) (76)
- Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases (1988) (76)
- Tumour necrosis factor alpha during human pregnancy and labour: maternal plasma and amniotic fluid concentrations and release from intrauterine tissues. (1994) (76)
- Potential use of rapamycin in HIV infection. (2010) (74)
- Serum Cardiac Troponin I in Acute Stroke Is Related to Serum Cortisol and TNF-α (2004) (72)
- The role of monocytes and T cells in 1,25-dihydroxyvitamin D3 mediated inhibition of B cell function in vitro. (1991) (71)
- Detection of Tumour Necrosis Factor from Lipopolysaccharide‐Stimulated Human Mononuclear Cells by Enzyme‐Linked Immunosorbent Assay and Cytotoxicity Bioassay (1988) (69)
- Bioactive and inactive forms of tumor necrosis factor-alpha in spinal fluid from patients with meningitis. (1991) (69)
- 1 alpha,25-Dihydroxyvitamin D3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin 1 in vitro. (1988) (68)
- High-affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro. (1993) (68)
- Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn's disease. (2012) (68)
- Neutralizing antibodies hamper IFNβ bioactivity and treatment effect on MRI in patients with MS (2006) (68)
- Human anti-interleukin 1α antibodies (1991) (68)
- Expression of α and β subunits of the integrin superfamily in articular cartilage from macroscopically normal and osteoarthritic human femoral heads (1998) (67)
- Increased plasma levels of IL-6 in bacteremic periodontis patients after scaling. (2006) (65)
- Autoantibodies against interleukin 1α in rheumatoid arthritis: association with long term radiographic outcome (2002) (64)
- Measurement of eosinophil cationic protein (ECP) and eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Time and temperature dependent spontaneous release in vitro demands standardized sample processing. (1993) (64)
- Systemic inflammatory responses during laparoscopic and open inguinal hernia repair: a randomised prospective study. (2000) (64)
- Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1 (2009) (64)
- Elucidation of IL-1/TGF-beta interactions in mouse chondrocyte cell line by genome-wide gene expression. (2005) (63)
- Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor‐α and interferon‐γ, and has potential in the treatment of arthritis (2003) (62)
- Cytokines and autoantibodies to cytokines (1995) (62)
- Distribution and Characterization of Autoantibodies to Interleukin 1α in Normal Human Sera (1990) (62)
- Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP (2009) (61)
- Immunogenicity of Anti-TNF-α Biotherapies: II. Clinical Relevance of Methods Used for Anti-Drug Antibody Detection (2015) (61)
- Personalized medicine: theranostics (therapeutics diagnostics) essential for rational use of tumor necrosis factor-alpha antagonists. (2013) (61)
- Changes in serum trough levels of infliximab during treatment intensification but not in anti-infliximab antibody detection are associated with clinical outcomes after therapeutic failure in Crohn's disease. (2015) (61)
- Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein I in Gambian children with cerebral malaria (1994) (60)
- Is there a need for immunopharmacologic guidance of anti-tumor necrosis factor therapies? (2011) (59)
- Possible role of IL-1, TNF-alpha, and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease. Thyroid Cell Group. (1989) (59)
- HIV‐protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO‐hybridized derivatives? (2017) (58)
- Anti-TNF-α biotherapies: perspectives for evidence-based personalized medicine. (2012) (58)
- Infections and treatment of patients with rheumatic diseases. (2008) (58)
- In vitro immunomodulatory effects of pentoxifylline. (1993) (58)
- Interleukin-10 and posttransplant lymphoproliferative disorder after kidney transplantation. (1999) (56)
- Pre‐existing IgG antibodies cross‐reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease (2013) (55)
- Cytokines in Plasma and Ultrafiltrate during Continuous Arteriovenous Haemofiltration (1993) (55)
- Enhancement of human adaptive immune responses by administration of a high-molecular-weight polysaccharide extract from the cyanobacterium Arthrospira platensis. (2008) (55)
- Anti-IFN BAb and NAb antibodies (2003) (54)
- Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells. (2004) (54)
- Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin‐6 signal transducer gp130 1 (1997) (54)
- Inhibitor of Interleukin 1 in Normal Human Urine (1988) (54)
- Eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Detection by enzyme-linked immunosorbent assay and purification from normal human urine. (1991) (52)
- Low production of interferon gamma is related to disease progression in HIV infection: evidence from a cohort of 347 HIV-infected individuals. (1997) (52)
- Differential release of interleukin-6 from human gestational tissues in association with labour and in vitro endotoxin treatment. (1996) (51)
- Modulation of human neutrophil and monocyte chemotaxis and superoxide responses by recombinant TNF-alpha and GM-CSF. (1988) (51)
- Melatonin suppresses markers of inflammation and oxidative damage in a human daytime endotoxemia model. (2014) (50)
- Mechanism of Action of Cyclosporin A (1984) (49)
- Fusidic acid, an immunosuppressive drug with functions similar to cyclosporin A. (1990) (49)
- Influence of tumour necrosis factor-alpha, tumour necrosis factor-beta and interferon-gamma, separately and added together with interleukin-1 beta, on the function of cultured human thyroid cells. (1994) (49)
- The Atherogenic Bacterium Porphyromonas gingivalis Evades Circulating Phagocytes by Adhering to Erythrocytes (2011) (48)
- Effects of human anti-IL-1 alpha autoantibodies on receptor binding and biological activities of IL-1. (1992) (48)
- CYCLOSPORIN FOR POLYMYOSITIS (1984) (48)
- Differential Sensitivity to β-Cell Secretagogues in Cultured Rat Pancreatic Islets Exposed to Human Interleukin-1β* (1989) (48)
- Deteriorating ischaemic stroke cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke (2002) (47)
- Metabolism and β-cell function of rat pancreatic islets exposed to human interleukin-1β in the presence of a high glucose concentration (1990) (47)
- Cytokines and T-lymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL-1 or IL-1ra. (1997) (47)
- Short exposure of rat pancreatic islets to interleukin-1 beta induces a sustained but reversible impairment in beta-cell function: influence of protease activation, gene transcription, and protein synthesis. (1991) (46)
- Cell saver for on-pump coronary operations reduces systemic inflammatory markers: a randomized trial. (2010) (46)
- The cytokine network in the pathogenesis of major depressive disorder. Close to translation? (2020) (46)
- The inflammatory cytokine response after autotransfusion of shed mediastinal blood (1998) (45)
- Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells. (2000) (45)
- Persistence of neutralizing antibodies after discontinuation of IFNβ therapy in patients with relapsing-remitting multiple sclerosis (2006) (45)
- Bacterial-stimulated cytokine production of peripheral mononuclear cells from patients of various periodontitis categories. (1995) (45)
- Interleukin 6: a functional and structural in vitro modulator of beta-cells from islets of Langerhans. (1990) (44)
- Influence of interleukin‐6 (IL‐6) autoantibodies on IL‐6 binding to cellular receptors (1995) (44)
- Epidermal tumour necrosis factor α and interleukin 6‐like activities in AIDS‐related Kaposi's sarcoma (1989) (43)
- High levels of neutralizing IL‐6 autoantibodies in 0.1% of apparently healthy blood donors (2004) (42)
- [Chronic fatigue syndrome--a controlled cross-sectional study]. (1994) (41)
- Single nucleotide polymorphisms in genes encoding toll-like receptors 7, 8 and 9 in Danish patients with systemic lupus erythematosus (2014) (41)
- Hypomethylating Agent 5‐Aza‐2′‐deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models (2014) (41)
- Effect of physical exercise on in vitro production of interleukin 1, interleukin 6, tumour necrosis factor-alpha, interleukin 2 and interferon-gamma. (1991) (41)
- Expression of interleukin-6-like molecules and tumour necrosis factor after topical treatment of psoriasis with a new vitamin D analogue (MC 903). (1989) (40)
- Influence of Phthalates on Cytokine Production in Monocytes and Macrophages: A Systematic Review of Experimental Trials (2015) (40)
- IL-2 induces beta2-integrin adhesion via a wortmannin/LY294002-sensitive, rapamycin-resistant pathway. Phosphorylation of a 125-kilodalton protein correlates with induction of adhesion, but not mitogenesis. (1996) (40)
- Interleukin‐1 affects the function of cultured human thyroid cells (1988) (40)
- TNF and LT binding capacities in the plasma of arthritis patients: effect of etanercept treatment in juvenile idiopathic arthritis. (2004) (40)
- Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease (2012) (40)
- Beta-galactosylceramide increases and sulfatide decreases cytokine and chemokine production in whole blood cells. (2004) (39)
- An interleukin-1 receptor antagonist protein protects insulin-producing Beta cells against suppressive effects of interleukin-1β (1991) (39)
- Increased In Vivo Antibody Activity Against Interferon α, Interleukin-1α, and Interleukin-6 After High-Dose Ig Therapy (1997) (39)
- The effect of interleukin-1 on the thyroid gland. (1993) (39)
- Increased plasma levels of soluble IL‐2R are associated with severe Plasmodium falciparum malaria (1994) (39)
- Influence of Phthalates on in vitro Innate and Adaptive Immune Responses (2015) (39)
- Production of interleukin (IL)‐5 and IL‐10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self‐antigen, thyroglobulin, in health and autoimmune thyroid disease (2006) (38)
- Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist (1997) (38)
- Nicotinamide decreases nitric oxide production and partially protects human pancreatic islets against the suppressive effects of combinations of cytokines. (1994) (38)
- Indirect assessment of eosinophiluria in urinary schistosomiasis using eosinophil cationic protein (ECP) and eosinophil protein X (EPX). (1993) (38)
- Blood cell gene expression profiling in subjects with aggressive periodontitis and chronic arthritis. (2008) (38)
- CD44 expression is up‐regulated in the deep zone of osteoarthritic cartilage from human femoral heads (1997) (38)
- Decreased cell replication and polyamine content in insulin-producing cells after exposure to human interleukin 1 beta. (1989) (38)
- The production of heterologous antibodies to the human lymphakine: leukocyte migration inhibitory factor (LIF). (1977) (37)
- Essential pathogenic role of endogenous IL‐18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL‐18‐binding protein: Fc construct (2003) (37)
- Biological Properties of Interleukins (1983) (37)
- Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor. (2011) (37)
- IL‐6 GENE POLYMORPHISM IN RHEUMATOID ARTHRITIS, PAUCIARTICULAR JUVENILE RHEUMATOID ARTHRITIS, SYSTEMIC LUPUS ERYTHEMATOSUS, AND IN HEALTHY DANES (1989) (37)
- Measuring and evaluating interferon b-induced antibodies in patients with multiple sclerosis (2006) (37)
- Are ex vivo neutralising antibodies against IFN-β always detrimental to therapeutic efficacy in multiple sclerosis? (2007) (37)
- Cytokines in inflammatory bowel disease. (1992) (36)
- Gasotransmitters and the immune system: Mode of action and novel therapeutic targets (2018) (36)
- Massive parallel gene expression profiling of RINm5F pancreatic islet β‐cells stimulated with interleukin‐1β (2000) (36)
- Biological anti-TNF drugs: immunogenicity underlying treatment failure and adverse events (2017) (36)
- Thyrocyte-interleukin-1 interactions. (2000) (35)
- AN IN VITRO ASSAY OF LEUKOCYTE MIGRATION INHIBITORY ACTIVITY FROM HUMAN LYMPHOCYTES STIMULATED WITH CONCANAVALIN A (1975) (35)
- Sex‐ and age‐dependency of IgG auto‐antibodies against IL‐1α in healthy humans (1994) (34)
- Proliferation induced by Plasmodium falciparum antigen and interleukin-2 production by lymphocytes isolated from malaria-immune individuals (1986) (34)
- Prevention of Spontaneous Autoimmune Diabetes in NOD Mice by Transferring in VitroAntigen-Pulsed Syngeneic Dendritic Cells. (2000) (34)
- B-cell depletion with rituximab in the treatment of autoimmune diseases (2007) (34)
- Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock. (1995) (33)
- Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches. (2019) (33)
- Circulating and mucosal concentrations of tumour necrosis factor and inhibitor(s) in chronic inflammatory bowel disease. (1993) (33)
- Abnormal vitamin D3 metabolism in patients with primary Sjögren's syndrome. (1990) (33)
- Effects of 1,25-dihydroxyvitamin D3 and the analogues MC903 and KH1060 on interleukin-1β-induced inhibition of rat pancreatic islet β-cell function in vitro (1994) (32)
- Labour-associated increase in interleukin-1 alpha release in vitro by human gestational tissues. (1996) (32)
- In vitro cytokine production and phenotype expression by blood mononuclear cellsfrom umbilical cords, children and adults (1996) (32)
- Interleukin-1 beta increases the biosynthesis of the heat shock protein hsp70 and selectively decreases the biosynthesis of five proteins in rat pancreatic islets. (1991) (32)
- LONG‐TERM FOLLOW‐UP OF KIDNEY TRANSPLANT PATIENTS WITH POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: DURATION OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER‐INDUCED OPERATIONAL GRAFT TOLERANCE, INTERLEUKIN‐18 COURSE, AND RESULTS OF RETRANSPLANTATION (2003) (32)
- Anti-diabetogenic effect of fusidic acid in diabetes prone BB rats. (1992) (31)
- Keratinocyte-expression of interleukin-6 but not of tumour necrosis factor-alpha is increased in the allergic and the irritant patch test reaction. (1991) (31)
- Protection from concanavalin A (Con A)‐induced T cell‐dependent hepatic lesions and modulation of cytokine release in mice by sodium fusidate (1997) (31)
- Genetic Variants in Toll-Like Receptors Are Not Associated with Rheumatoid Arthritis Susceptibility or Anti-Tumour Necrosis Factor Treatment Outcome (2010) (31)
- The CC-chemokine receptor 5 (CCR5) is a marker of, but not essential for the development of human Th1 cells. (1999) (31)
- Immunocytochemical localisation of interleukin-1 alpha and interleukin-6 in thyroid tissues from patients with neoplastic or autoimmune thyroid disorders. (1995) (31)
- Specific and Strain‐Independent Effects of Dexamethasone in the Prevention and Treatment of Experimental Autoimmune Encephalomyelitis in Rodents (2010) (31)
- Methotrexate induces poly(ADP‐ribose) polymerase‐dependent, caspase 3‐independent apoptosis in subsets of proliferating CD4+ T cells (2007) (30)
- Effect of methylprednisolone on the cytokine response in patients undergoing lung surgery (1993) (30)
- Pronounced Inflammatory Response to Endotoxaemia during Nighttime: A Randomised Cross-Over Trial (2014) (30)
- Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients (2010) (30)
- INHIBITION OF HUMAN LEUKOCYTE MIGRATION INHIBITORY FACTOR (LIF) BY α‐L‐FUCOSE (1975) (30)
- Recombinant Interleukin α and ß Prime Human Monocyte Superoxide Production but Have no Effect on Chemotaxis and Oxidative Burst Response of Neutrophils (1988) (30)
- Human Leukocyte Migration Inhibitory Factor (LIF) (1977) (30)
- Production of IL-1beta, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE. (1999) (29)
- MHC class II molecules regulate growth in human T cells. (1994) (29)
- Human Leucocyte Migration Inhibition (1976) (29)
- Detection of autoantibodies to cytokines (2000) (29)
- Vaccination for birch pollen allergy. Induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1. (2003) (29)
- Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment. (1989) (29)
- Elevated plasma interleukin 6: a biochemical marker of human preterm labour. (1993) (28)
- Anti‐Interleukin‐6 Autoantibodies in Plasma are Associated with an Increased Frequency of Infections and Increased Mortality of Patients with Alcoholic Cirrhosis (1996) (28)
- Inhibitory Effect of Cyclosporin A on Histamine Release from Human Leukocytes and Rat Mast Cells (1985) (28)
- The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major. (1998) (27)
- Immunogenicity of Anti-TNF-α Biotherapies: I. Individualized Medicine Based on Immunopharmacological Evidence (2015) (27)
- Fusidic acid for Behçet's colitis: a novel approach to T-cell specific immunosuppressive therapy. (1991) (27)
- Spironolactone induces apoptosis and inhibits NF-κB independent of the mineralocorticoid receptor (2006) (27)
- Effects of spironolactone on human blood mononuclear cells: mineralocorticoid receptor independent effects on gene expression and late apoptosis induction (2006) (27)
- Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors. (2009) (27)
- Treatment of Crohn's disease with fusidic acid: an antibiotic with immunosuppressive properties similar to cyclosporin (1992) (27)
- Demonstration of circulating leukocytic pyrogen/interleukin-1 during fever. (1984) (27)
- The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis (2009) (26)
- Interleukin‐6 and tumour necrosis factor alpha are expressed by keratinocytes but not by Langerhans cells (1991) (26)
- Anti-Drug Antibodies, Drug Levels, Interleukin-6 and Soluble TNF Receptors in Rheumatoid Arthritis Patients during the First 6 Months of Treatment with Adalimumab or Infliximab: A Descriptive Cohort Study (2016) (26)
- Serum‐induced suppression of interferon (IFN) activity. Lack of evidence for the presence of specific autoantibodies to IFN‐α in normal human sera (1992) (26)
- Naturally Occurring Autoantibodies to Interleukin-1α, Interleukin-6, Interleukin-10, and Interferon-α (1994) (26)
- Macrophage-derived cytokines in the follicular fluids of women with infertility due to immunological causes. Elevated levels of interleukin 6 and low levels of granulocyte-macrophage colony-stimulating factor. (1998) (26)
- EBV-induced post-transplant lymphoproliferative disorder (PTLD). (1995) (26)
- Down-regulation of monocyte functions by treatment of healthy adults with 1 alpha,25 dihydroxyvitamin D3. (1991) (26)
- The influence of interleukin-1 on the function of in vitro cultured human thyroid cells in monolayers. (1987) (25)
- Cytokine autoantibodies in rheumatoid arthritis. (1995) (25)
- Investigation of immunosuppressive properties of inactivated human immunodeficiency virus and possible neutralization of this effect by some patient sera. (1989) (25)
- Quantitative assessment of clinical disease status in primary Sjögren's syndrome. A cross-sectional study using a new classification model. (1997) (25)
- Interleukin-6 autoantibodies: possible biological and clinical significance. (1995) (25)
- Selective Modulation of the CD4 Molecular Complex by Pseudomonas aeruginosa Alkaline Protease and Elastase (1987) (25)
- Multiplex Screening of 22 Single-Nucleotide Polymorphisms in 7 Toll-like Receptors: An Association Study in Rheumatoid Arthritis (2010) (24)
- Cell‐mediated immune responses to soluble Plasmodium falciparum antigens in residents from an area of unstable malaria transmission in the Sudan (1990) (24)
- Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production (2011) (24)
- Influence of Protease on Inhibitory and Stimulatory Effects of Interleukin 1β on β-Cell Function (1991) (24)
- Antigenicity and protein content of perilymph in acoustic neuroma patients. (1984) (24)
- An interleukin-1 receptor antagonist protein protects insulin-producing beta cells against suppressive effects of interleukin-1 beta. (1991) (24)
- Involvement of interleukin-1 genotypes in the association of coronary heart disease with periodontitis. (2008) (24)
- Stimulation of the B9 hybridoma cell line by soluble interleukin-6 receptors. (1994) (24)
- IgG autoantibodies against interleukin 1 alpha in sera of normal individuals. (1989) (23)
- Molecular cloning and expression of a novel Staphylococcus aureus antigen. (1997) (23)
- Treatment of chronic endogenous uveitis with fusidic acid (1991) (23)
- Biomolecular regulation of the IgE immune response (1992) (23)
- Genetic polymorphisms of dsRNA ligating pattern recognition receptors TLR3, MDA5, and RIG-I. Association with systemic lupus erythematosus and clinical phenotypes (2014) (23)
- Differential binding of human interleukin‐1 (IL‐1) receptor antagonist to natural and recombinant soluble and cellular IL‐1 type I receptors (1995) (23)
- Sulphatide and its precursor galactosylceramide influence the production of cytokines in human mononuclear cells (1996) (23)
- Role of receptor binding and gene transcription for both the stimulatory and inhibitory effects of interleukin-1 in pancreatic beta-cells. (1992) (23)
- Time Course and Clinical Implications of Development of Antibodies Against Adalimumab in Patients With Inflammatory Bowel Disease (2016) (23)
- Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-gamma. (1994) (23)
- Interleukin-1 receptors on human thyroid cells and on the rat thyroid cell line FRTL-5. (1991) (23)
- Is the treatment effect of IFN-β restored after the disappearance of neutralizing antibodies? (2008) (23)
- The effect of spironolactone on experimental periodontitis in rats. (2005) (22)
- Liposomal delivery of antioxidant enzymes protects against hydrogen peroxide- but not interleukin-1 beta-induced inhibition of glucose metabolism in rat pancreatic islets. (1994) (22)
- Human Leukocyte Migration Inhibitory Factor (LIF) (1977) (22)
- Differential effect of conditioning regimens on cytokine responses during allogeneic stem cell transplantation (2006) (22)
- In vitro production of cytokines is influenced by sulfatide and its precursor galactosylceramide (1999) (22)
- Expression of alpha and beta subunits of the integrin superfamily in articular cartilage from macroscopically normal and osteoarthritic human femoral heads. (1998) (22)
- Lower limb ischaemia and reperfusion injury in healthy volunteers measured by oxidative and inflammatory biomarkers (2015) (21)
- Cytokine vaccination: neutralising IL-1α autoantibodies induced by immunisation with homologous IL-1α (2000) (21)
- Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulated with phytohemagglutinin. I. Effect of various metabolic inhibitors. (1981) (21)
- Tumour necrosis factor‐α (TNF), lymphotoxin and TNF receptor levels in serum from patients with Wegener's granulomatosis (2001) (21)
- Methylprednisolone does not restore biological response in multiple sclerosis patients with neutralizing antibodies against interferon‐β (2009) (21)
- Effect of fusidic acid on interleukin-1 (IL-1)- and IL-6-induced pancreatic beta-cell functions in rats. (1992) (21)
- Cholesterol crystals enhance TLR2- and TLR4-mediated pro-inflammatory cytokine responses of monocytes to the proatherogenic oral bacterium Porphyromonas gingivalis (2017) (21)
- Improved survival and antagonistic effect of sodium fusidate on tumor necrosis factor alpha in a neonatal mouse model of endotoxin shock (1996) (21)
- Increased in vivo antibody activity against interferon alpha, interleukin-1alpha, and interleukin-6 after high-dose Ig therapy. (1997) (21)
- Interleukin-1-like activities in synovial fluids of patients with rheumatoid arthritis and traumatic synovitis (2004) (20)
- Human Leucocyte Migration Inhibitory Factor (LIF) (1978) (20)
- Immunosuppressive actions of gold salts. (1983) (20)
- Production of interferon-gamma and interleukin-4 by human T cells recognizing Leishmania lipophosphoglycan-associated protein. (1993) (20)
- Recombinant human tumour necrosis factor increases cytosolic free calcium in murine fibroblasts and stimulates inositol phosphate formation in L-M and arachidonic acid release in 3T3 cells. (1990) (20)
- Role of Zn2+ and Other Divalent Metal Ions in Human Lymphokine Production in Vitro (1982) (20)
- Immunolocalisation of Interleukin-4 and Interleukin-4 Receptor in Placenta and Fetal Membranes in Association with Pre-Term Labour and Pre-Eclampsia (1998) (20)
- Comparison of mRNA contents of interleukin-1Β and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice (1995) (20)
- The Effects of Interleukin-1β (IL-1β) on Human Thyrocyte Functions Are Counteracted by the IL-1 Receptor Antagonist. (1997) (20)
- GM-CSF autoantibodies in pulmonary alveolar proteinosis. (2007) (19)
- Cytokines and soluble IL‐4 in patients with acute optic neuritis and multiple sclerosis (1997) (19)
- Expression of an insulin/interleukin-1 receptor antagonist hybrid gene in insulin-producing cell lines (HIT-T15 and NIT-1) confers resistance against interleukin-1-induced nitric oxide production. (1995) (19)
- Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial (2014) (19)
- Human Leukocyte Migration Inhibitory Factor (LIF) (1977) (19)
- Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women (2004) (19)
- Autoantibodies to cytokines in IVIG. (1993) (18)
- Differential effects of interleukin 1α and 1β on cultured human and rat thyroid epithelial cells (1990) (18)
- Influence of interleukin 6 on the function of secondary cultures of human thyrocytes. (1991) (18)
- Critical review: assessment of interferon-β immunogenicity in multiple sclerosis. (2010) (18)
- Soluble tumor necrosis factor (TNF) receptors conserve TNF bioactivity in meningitis patient spinal fluid. (1996) (18)
- Soluble products of inflammatory reactions are not induced in children with asymptomatic Plasmodium falciparum infections (1996) (18)
- Differential interleukin-6 (IL-6) responses of three established myeloma cell lines in the presence of soluble human IL-6 receptors. (1996) (18)
- Increased circulating levels of interleukin-6 in HIV-seropositive subjects. (1996) (18)
- Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease (2016) (18)
- Involvement of Interleukin-1 Genotypes in the Association of Coronary Heart Disease With Periodontitis (2008) (17)
- Effect of antimalarial drugs on stimulation and interleukin 2 production of human lymphocytes. (1987) (17)
- Lack of anti-drug antibodies in patients with psoriasis well-controlled on long-term treatment with tumour necrosis factor inhibitors. (2012) (17)
- Staphylococcal enterotoxin-A directly stimulates signal transduction and interferon-gamma production in psoriatic T-cell lines. (1998) (17)
- Cultures of Human Colonic Epithelial Cells Isolated from Endoscopical Biopsies from Patients with Inflammatory Bowel Disease. Effect of IFNγ, TNFα and IL-1β on Viability, Butyrate Oxidation and IL-8 Secretion (2000) (17)
- Effects of Prolonged Exposure in Vitro to Interferon-γ and Tumour Necrosis Factor-α on Nitric Oxide and Insulin Production of Rat Pancreatic Islets (1995) (17)
- Effect of cyclosporin A (CyA) on the immune response. CyA competitively inhibits the function of monocyte/macrophage-derived T-lymphocyte-activating factor(s). (1982) (17)
- Effects of Growth Factors on Cytokine Production in Serum‐Free Cultures of Human Thymic Epithelial Cells (1993) (17)
- Epidermal tumour necrosis factor alpha and interleukin 6-like activities in AIDS-related Kaposi's sarcoma. An immunohistological study. (1989) (17)
- Some physicochemical properties of human leucocyte migration inhibitory factor (LIF). (1976) (16)
- Differential Role of Zn2+ in Antigen‐ and Mitogen‐induced Lymphokine Production (1980) (16)
- Antibodies to Infliximab and Adalimumab in Patients with Rheumatoid Arthritis in Clinical Remission: A Cross-Sectional Study (2015) (16)
- Serum levels of C-reactive protein in adolescents with periodontitis. (2011) (16)
- The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis. (2008) (16)
- Prevention of murine experimental autoimmune orchitis by recombinant human interleukin-6. (2002) (16)
- Proinflammatory effects of exogenously administered IL-10 in experimental autoimmune orchitis. (2003) (16)
- Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice. (1999) (16)
- Native inhibitors (autoantibodies) of IL-1α and TNF (1989) (15)
- Vaccination with IL-6 analogues induces autoantibodies to IL-6 and influences experimentally induced inflammation. (2007) (15)
- Leucocyte migration inhibitory activity of concanavalin-A-stimulated human lymphocytes. Modification by dipyridamole, lysine-acetylsalicylate and heparin. (2009) (15)
- Tumor necrosis factor-alpha increases myocardial microvascular transport in vivo. (1994) (15)
- Neutralizing antibodies to interferon (IFN) α-2a and IFN β-1a or IFN β-1b in MS are not cross-reactive (2000) (15)
- Functional characteristics of synovial fluid and blood mononuclear cells in rheumatoid arthritis and traumatic synovitis. (1982) (15)
- Human Leukocyte Migration Inhibitory Factor (LIF) (1977) (15)
- Human anti-interleukin 1 alpha antibodies. (1991) (15)
- The peri-operative cytokine response in infants and young children following major surgery. (1998) (15)
- [Spironolactone inhibits production of proinflammatory cytokines, including tumor necrosis factor-alpha and interferon-gamma and has potential effect in the treatment of arthritis]. (2004) (15)
- 1,25-Dihydroxyvitamin D3-mediated suppression of T lymphocyte functions and failure of T cell-activating cytokines to restore proliferation. (1992) (15)
- Effects of natural and recombinant interleukin-1 alpha and -beta on cytosolic free calcium in human and murine fibroblasts. (1988) (15)
- Increased expression of complement receptor type 1 (CR1, CD35) on human peripheral blood T lymphocytes after polyclonal activation in vitro (1995) (14)
- Immunoregulation by Naturally Occurring and Disease-Associated Autoantibodies (2012) (14)
- Induction of antigen-specific lymphocyte unresponsiveness in vitro: possible role of divalent cations and defective function of human T-cell-activating factor (TAF). (1982) (14)
- Interleukin-6 (IL-6) autoantibodies and blood IL-6 measurements [letter] (1995) (14)
- Decreased interleukin-2 responses to Fusobacterium nucleatum and Porphyromonas gingivalis in generalized aggressive periodontitis. (2009) (14)
- Nitric Oxide Production is not involved in the Effects of Interleukin-1β on CAMP, Thyroglobulin and Interleukin-6 in TSH-Stimulated Human Thyroid Cells (1994) (14)
- Production of leucocyte migration inhibitory factor (LIF) in infectious mononucleosis. Spontaneous release and lack of response to concanavalin A. (1978) (14)
- Knocking out IL‐6 by vaccination (2004) (14)
- In Vitro Cytokine Responses to Periodontal Pathogens: Generalized Aggressive Periodontitis is Associated with Increased IL‐6 Response to Porphyromonas gingivalis (2010) (14)
- Plasma cytokines in acute stroke. (2002) (14)
- Variation in NOD2 Augments Th2- and Th17 Responses to Myelin Basic Protein in Multiple Sclerosis (2011) (14)
- Ciclosporin (Cyclosporin A): Prototype of a New Generation of Immunosuppressive Drugs (1984) (14)
- [Clinical importance of neutralising antibodies against interferon-beta in patients with relapsing-remitting multiple sclerosis]. (2004) (14)
- The effects of interleukin-1beta (IL-1beta) on human thyrocyte functions are counteracted by the IL-1 receptor antagonist. (1997) (14)
- Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis (2009) (14)
- Cytokines in autoimmunity. (1987) (14)
- Specific autoantibodies directed against interferon-alpha in pharmaceutically prepared human immunoglobulin preparations. (1994) (14)
- Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin. (2000) (14)
- In vitro inhibition of enterobacteria-reactive CD4+CD25- T cells and suppression of immunoinflammatory colitis in mice by the novel immunomodulatory agent VGX-1027. (2008) (14)
- Biomolecular regulation of the IgE immune response III. Cytokine profiles in atopic dermatitis, inhalant allergy and non-allergic donors. (1996) (13)
- Phthalates Are Metabolised by Primary Thyroid Cell Cultures but Have Limited Influence on Selected Thyroid Cell Functions In Vitro (2016) (13)
- Influence of apolipoprotein E plasma levels and tobacco smoking on the induction of neutralising antibodies to interferon-beta (2010) (13)
- Letter: persistence of anti‐infliximab antibodies after discontinuation of infliximab in patients with IBD (2012) (13)
- CD26+CD4+T cell counts and attack risk in interferon-treated multiple sclerosis (2005) (13)
- Cytokine vaccination: neutralising IL-1alpha autoantibodies induced by immunisation with homologous IL-1alpha. (2000) (13)
- Sodium fusidate in Guillain-Barré syndrome: a case report (1998) (13)
- Effects of Immunomodulators on Ecto‐5′‐Nucleotidase Activity on Blood Mononuclear Cells In Vitro (1992) (13)
- Thl‐Like Human T‐Cell Clones Recognizing Leishmania gp63 Inhibit Leishmania major in Human Macrophages (1994) (13)
- Plasma TNF binding capacity profiles during treatment with etanercept in rheumatoid arthritis (2004) (13)
- A Role for Cyclosporin A in the Treatment of Insulin‐dependent Diabetes Mellitus? (1985) (13)
- Immunochemical and Biological Reactivity of Human Anti‐Lipopolysaccharide IgG Obtained by Screening of Blood Donors (1989) (13)
- Seasonal Variations in T-Lymphocyte Response to Grass Pollen Allergens from Pollen-Allergic Patients and Healthy Controls (1998) (13)
- Cytokine-induced impairment of short-chain fatty acid oxidation and viability in human colonic epithelial cells. (2000) (13)
- Prevention of carrageenan-induced pleurisy in mice by anti-CD30 ligand monoclonal antibody. (2004) (13)
- Involvement of monokines in antigen- and lectin-induced human lymphokine production. (2009) (12)
- An Imidazoline Compound Completely Counteracts Interleukin-1β toxic Effects to Rat Pancreatic Islet β Cells (2002) (12)
- Specific cellular immunity in acoustic neuroma patients (1983) (12)
- Tumor necrosis factor-β in human pregnancy and labor☆ (1997) (12)
- Fusidic acid and insulin-dependent diabetes mellitus. (1996) (12)
- MspI polymorphism in the human interleukin 6 (IL 6) gene. (1989) (12)
- Recombinant human tumour necrosis factor is not inhibitory to Plasmodium falciparum in vitro. (1988) (11)
- Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis. (2008) (11)
- Production of leukocyte migration inhibitory factor (LIF) in human lymphocyte subsets exposed to polyclonal activators. (1984) (11)
- Effect of methylprednisolone on the cytokine response in patients undergoing lung surgery. (1992) (11)
- Self-Reactive CD4+ T Cells and B Cells in the Blood in Health and Autoimmune Disease: Increased Frequency of Thyroglobulin-Reactive Cells in Graves’ Disease (2006) (11)
- Adhesion molecules in inflammatory and neoplastic intestinal diseases. (1995) (11)
- Effects of cyclosporin A (CyA) and methylprednisolone (MP) on the immune response. I. T-cell-activating factor abrogates CyA- but not MP-induced suppression of antigen-induced lymphokine production. (1982) (11)
- Massive parallel gene expression profiling of RINm5F pancreatic islet beta-cells stimulated with interleukin-1beta. (2000) (11)
- Increased polymorphonuclear leukocyte cGMP levels induced by the human lympholine, leukocyte migration inhibitory factor (LIF). (1979) (10)
- Metabolism and beta-cell function of rat pancreatic islets exposed to human interleukin-1 beta in the presence of a high glucose concentration. (1990) (10)
- Influence of endotoxin on production of leucocyte migration inhibition factor. Part I. (1984) (10)
- Effects of the immunomodulator, VGX‐1027, in endotoxin‐induced uveitis in Lewis rats (2008) (10)
- Recombinant interleukin 1 alpha and beta prime human monocyte superoxide production but have no effect on chemotaxis and oxidative burst response of neutrophils. (1988) (10)
- POSSIBLE CORRELATION OF TNFα‐PRODUCTION WITH ‐RFLP IN HUMANS (1989) (10)
- Effects of 1,25-dihydroxyvitamin D3 and the analogues MC903 and KH1060 on interleukin-1 beta-induced inhibition of rat pancreatic islet beta-cell function in vitro. (1994) (10)
- Decreased Short-Term Production of Tumor Necrosis Factor-α and Interleukin-1β in Human Immunodeficiency Virus-Seropositive Subjects (1997) (10)
- IFN-α Antibodies in Patients with Age-Related Macular Degeneration Treated with Recombinant Human IFN-α2a (2002) (10)
- Pattern recognition receptor polymorphisms in early periodontitis. (2019) (10)
- Biological assays for interleukin 1 detection (1991) (10)
- Interleukin-8 production from human somatotroph adenoma cells is stimulated by interleukin-1β and inhibited by growth hormone releasing hormone and somatostatin. (2011) (10)
- Case Study: Immunogenicity of Anti-TNF Antibodies (2008) (9)
- A standardized human T-lymphocyte proliferation assay for detecting soluble accessory factors from monocytes. I. Monocyte and monokine requirements. (2009) (9)
- Immunocytochemical localisation of tumor necrosis factor alpha in thyroid tissues from patients with neoplastic or autoimmune thyroid disorders. (1996) (9)
- Interleukin-10 and Epstein-Barr virus-induced posttransplant lymphoproliferative disorder. (1996) (9)
- Spironolactone induces apoptosis in human mononuclear cells. Association between apoptosis and cytokine suppression (2006) (9)
- Gene expression profiling in autoimmune diseases: Chronic inflammation or disease specific patterns? (2007) (9)
- IgG for intravenous use, autologous serum and plasma induce comparable interleukin-1 receptor antagonist liberation from human mononuclear cells: an in vitro phenomenon depending upon plastic adherence. (1995) (9)
- Leukocyte migration inhibitory factor: a serine esterase released by stimulated human lymphocytes. Kinetic analysis and inhibition by cyclic GMP. (1979) (9)
- Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta. (1989) (9)
- Anti-IL-1alpha autoantibodies in early rheumatoid arthritis. (2001) (9)
- Naturally occurring autoantibodies to interleukin-1 alpha, interleukin-6, interleukin-10, and interferon-alpha. (1994) (9)
- Affinity chromatography. A new technique for partial purification of human leucocyte migration inhibitory factor. (1976) (9)
- Cytokine‐induced histamine release from basophils of AIDS patients (1991) (9)
- Cultures of human colonic epithelial cells isolated from endoscopical biopsies from patients with inflammatory bowel disease. Effect of IFNgamma, TNFalpha and IL-1beta on viability, butyrate oxidation and IL-8 secretion. (2000) (9)
- Liposome-mediated transfer of IL-1 receptor antagonist gene to dispersed islet cells does not prevent recurrence of disease in syngeneically transplanted NOD mice. (2000) (8)
- Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barrè syndrome (2008) (8)
- Autoantibodies to IL-1 alpha in sera from umbilical cords, children, and adults, and from patients with juvenile chronic arthritis. (1996) (8)
- Sodium fusidate in steroid resistant relapses of multiple sclerosis. (1999) (8)
- Maturation of human dendritic cells by monocyte-conditioned medium is dependent upon trace amounts of lipopolysaccharide inducing tumour necrosis factor alpha. (2003) (8)
- Interleukin-6 (IL-6) autoantibodies and blood IL-6 measurements. (1995) (8)
- Biomolecular regulation of the IgE immune response. II. In vitro IgE synthesis and spontaneous production of cytokines. (1995) (8)
- Sex- and age-dependency of IgG auto-antibodies against IL-1 alpha in healthy humans. (1994) (8)
- Interleukin 1, but not Interleukin 1 Inhibitor, is Released from Human Monocytes by Immune Complexes (1990) (8)
- Effect of melatonin on human nighttime endotoxaemia: randomized, double-blinded, cross-over study. (2014) (8)
- Neutralizing antibodies to interferon (IFN) alpha-2a and IFN beta-1a or IFN beta-1b in MS are not cross-reactive. (2000) (8)
- Enzyme Immunoassays and Radioimmunoassays for Quantification of Anti‐TNF Biopharmaceuticals and Anti‐Drug Antibodies (2011) (8)
- Sodium fusidate (fusidin) ameliorates the course of monophasic experimental allergic encephalomyelitis in the Lewis rat (2001) (8)
- Biological Properties of Lymphokines (1978) (8)
- Tumour necrosis factor-alpha (TNF), lymphotoxin and TNF receptor levels in serum from patients with Wegener's granulomatosis. (2001) (8)
- Leucocyte migration inhibitory activity of concanavalin-A-stimulated lymphocytes. In vivo and in vitro modifications with dipyridamole and acetylsalicylic acid. (2009) (8)
- Influence of protease on inhibitory and stimulatory effects of interleukin 1 beta on beta-cell function. (1991) (8)
- 94 Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab: The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial (2013) (7)
- Quantitation and biological activities of native tumour necrosis factor from LPS‐stimulated human monocytes (1990) (7)
- Human monocyte elastolytic activity, the propeptides of types I and III procollagen, proteoglycans, and interleukin-6 in synovial fluid from patients with arthritis. (1991) (7)
- Nephrotoxicity of Cyclosporin A in Patients with Newly Diagnosed Type 1 Diabetes Mellitus (1990) (7)
- Interleukins increase surface ganglioside expression of pancreatic islet cells in vitro (1992) (7)
- Infusion of hypertonic saline before elective hysterectomy: effects on cytokines and stress hormones. (2008) (7)
- EGNA-specific LIF production of human lymphocyte subsets. (1984) (7)
- Interleukin-6 is not a second mediator of interleukin-1 induced suppression of thyroid function in cultured human thyrocytes. (2009) (7)
- Cytokine responses in infants infected with respiratory syncytial virus (2012) (7)
- Patient-specific cell-mediated immunity against human acoustic neuroma extract. (1982) (7)
- Production of interleukin (IL)-1beta, IL-1 receptor antagonist and IL-10 by blood mononuclear cells in chronic arthritis. (2000) (7)
- Chronic fatigue syndrome--a controlled cross sectional study. (1994) (7)
- SCLEROSING PERITONITIS AND PRACTOLOL (1975) (7)
- Blood levels of CD11bH+ memory T lymphocytes are selectively upregulated in patients with active rheumatoid arthritis (1999) (7)
- Interleukin-1 receptor antagonist in neonates, children and adults, and in patients with pauci- and polyarticular onset juvenile chronic arthritis. (1997) (7)
- Cytokines and soluble tumour necrosis factor I receptor levels during pretransplant conditioning in allogeneic stem-cell transplantation. (2005) (7)
- Distribution and characterization of autoantibodies to interleukin 1 alpha in normal human sera. (1990) (7)
- Measurement of human IL-1 by LIF induction, pancreatic islet-cell cytotoxicity, and bone resorption. (1986) (6)
- Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats. (2003) (6)
- Why is too little TNF bad? (1991) (6)
- Lack of effect of intermittently administered sodium fusidate in patients with newly diagnosed type 1 diabetes mellitus: the FUSIDM trial (2005) (6)
- Human urine deoxyribonuclease increases endogenous thymidine in the mouse thymocyte interleukin 1 assay: an artificial interleukin-1 inhibitor. (1989) (6)
- Incidence of acute severe infusion reactions to infliximab depends on definition used rather than assay: authors’ reply (2011) (6)
- Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulated with phytohemagglutinin. II. Effects of cyclic nucleotides. (1981) (6)
- Effects of cyclosporin A (CyA) and methylprednisolone (MP) on the immune response. II. Further studies of the monocyte - T cell interactions leading to lymphokine production. (1983) (6)
- Blood mononuclear cells in patients with primary Sjögren's syndrome: production of interleukins, enumeration of interleukin-2 receptors, and DNA synthesis. (1986) (5)
- Can Measurements of Anti-Infliximab Antibodies Predict Acute Severe Infusion Reactions to Infliximab? (2011) (5)
- Inhibition of LPS and Plasmodium falciparum Induced Cytokine Secretion by Pentoxifylline and Two Analogues (1997) (5)
- Decreased plasma levels of factor II+VII+X correlate with increased levels of soluble cytokine receptors in patients with malaria and meningococcal infections (1997) (5)
- Differential effects of interleukin 1 alpha and 1 beta on cultured human and rat thyroid epithelial cells. (1990) (5)
- The antimalarial drug, Ro 42-1611 (arteflene), does not affect cytoadherence and cytokine-inducing properties of Plasmodium falciparum malaria parasites. (1995) (5)
- Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease (2020) (5)
- Lewis and AB0 blood group-phenotypes in periodontitis, cardiovascular disease, obesity and stroke (2019) (5)
- Natural and therapy-induced antibodies to cytokines. (2004) (5)
- IFN-alpha antibodies in patients with age-related macular degeneration treated with recombinant human IFN-alpha2a. (2002) (5)
- [Chemokines and HIV infection]. (1997) (5)
- Abnormal vitamin D 3 metabolism in patients with primary Sjogren ' s syndrome (5)
- Comment on ‘Predicting the response to infliximab from trough serum levels’ (2010) (5)
- Use of benzoyl-L-phenylalanyl-L-valyl-L-arginine (3H) methyl ester as a sensitive and selective substrate for the human lymphokine, leukocyte migration inhibitory factor (LIF). (1980) (5)
- Pathogenic role of interleukin 1 and tumor necrosis factor in autoimmune endocrine diseases (1988) (5)
- Partial purification of human leucocyte migration inhibitory factor (LIF) by immunosorption of supernatant protein contaminants detected by crossed immunoelectrophorsis. (1976) (5)
- Plasma TNF binding capacity in patients with juvenile idiopathic arthritis. (2005) (5)
- Immunological studies in thymectomized and non-thymectomized patients with myasthenia gravis. (1978) (5)
- Effects of Leukotrienes on Neutrophil Migration, and on Production and Action of Lymphokines (1984) (5)
- Tu1236 Comparison of Techniques for Monitoring Infliximab Bioavailability and Immunogenicity in Crohn's Disease (2012) (5)
- Elastolytic activity of human monocytes from synovial fluid and blood of patients with arthritis. Relations to levels of interleukin 6 and soluble interleukin 2 receptor. (1991) (4)
- Cytokine production in NOD mice on prophylactic insulin therapy (1999) (4)
- Nitric oxide production is not involved in the effects of interleukin-1 beta on cAMP, thyroglobulin and interleukin-6 in TSH-stimulated human thyroid cells. (1994) (4)
- Interleukin-1α: A paracrine mediator of human term labour? (1994) (4)
- A matrix of cholesterol crystals, but not cholesterol alone, primes human monocytes/macrophages for excessive endotoxin-induced production of tumor necrosis factor-alpha. Role in atherosclerotic inflammation? (2014) (4)
- Lymphocyte function and chromosome aberrations in patients with early mycosis fungoides and parapsoriasis en plaques. (1983) (4)
- Native inhibitors (autoantibodies) of IL-1 alpha and TNF. (1989) (4)
- Tumor necrosis factor-beta in human pregnancy and labor. (1997) (4)
- Natural And Induced Anticytokine Antibodies In Humans (2000) (4)
- Optimisation of the CT h4S bioassay for detection of human interleukin-4 secreted by mononuclear cells stimulated by phytohaemaglutinin or by human leukocyte antigen mismatched mixed lymphocyte culture. (2002) (4)
- [The immune system and inflammatory diseases]. (2008) (4)
- Effect of human leucocyte migration inhibitory factor (LIF) on 3', 5'-cyclic AMP levels of peripheral blood leucocytes. (2009) (4)
- Role of monocytes/macrophages and interleukin 1 in antigen-induced human lymphokine production. (1984) (4)
- BglII polymorphism in the human interleukin 6 (IL 6) gene. (1989) (4)
- [Rituximab (MabThera) as treatment of active rheumatoid arthritis]. (2006) (4)
- Blood levels of CD11b+ memory T lymphocytes are selectively upregulated in patients with active rheumatoid arthritis. (1999) (4)
- In vitro modulation of human leucocyte migration and migration inhibitory factor (LIF) activity by cyclic 3',5'-AMP and cyclic 3',5'-GMP. (2009) (4)
- Studies on the active site of human leukocytic pyrogen (1982) (4)
- Interleukin 1‐Induced Down‐Regulation of Antibody Binding to CD4 Molecules on Human Lymphocytes (1988) (4)
- Ciclosporin Treatment of Autoimmune Inflammatory Disorders of the Eye (1985) (4)
- Inflammatory, non-antibody lymphocytic mediators (lymphokines). (1980) (3)
- Lymphokines and soluble interleukin-2 receptors in juvenile chronic arthritis (1992) (3)
- Letter: can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab? (2017) (3)
- [Extraintestinal manifestations in inflammatory bowel disease]. (2009) (3)
- [Treatment of rheumatoid arthritis (RA) with anti-TNF-alpha antibody (Remicade). Individual monitoring of bioavailability and immunogenicity--secondary publication]. (2007) (3)
- ROLE OF 1,25-DIHYDROXYVITAMIN D3 (l,25(OH)2D3) AS MODULATOR OF IMMUNOINFLAMMATORY REACTIONS (1991) (3)
- Monitoring immunogenicity of protein-based TNF antagonists (2015) (3)
- INTERLEUKIN 6: A FUNCTIONAL AND CELLS FROM ISLETS OF LANGERHANS STRUCTURAL IN VZTRO MODULATOR OF BETA- (1990) (3)
- Modulation of human leucocyte migration inhibitory factor (LIF) by 3',5'-cyclic AMP, 3',5'-cyclic GMP and agents known to influence intracellular cyclic nucleotide metabolism. (2009) (3)
- P536 Clinical implications of measuring drug and anti-drug antibodies by different assays when optimizing infliximab treatment failure in Crohn's disease (2014) (3)
- Determination of the human lymphokine leukocyte migration inhibitory factor (LIF) by a sensitive radioenzymatic assay. Inhibitory effect of cGMP on the esterolytic activity of highly purified LIF. (1979) (3)
- Antibodies Against “Human” Biopharmaceuticals: Individualized Therapy with TNF-alpha Inhibitors Guided by Immunopharmacologic Assessments (2014) (3)
- Cytokines modulate IgE-mediated histamine liberation from human basophils (1992) (3)
- The treatment of presumed non‐infective uveitis with Ciclosporin A (1985) (3)
- Cytokine-induced release of histamine from basophil leukocytes from AIDS patients (1990) (3)
- Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors. (1977) (3)
- Effects of prolonged exposure in vitro to interferon-gamma and tumour necrosis factor-alpha on nitric oxide and insulin production of rat pancreatic islets. (1995) (3)
- [Ampicillin induced bacteriuria in children]. (1973) (2)
- Substrate Specificity of the Human Lymphokine Leucocyte Migration‐Inhibitory Factor (LIF): Radioenzymic Assay and Inhibition by cGMP (1979) (2)
- Regulation during Inflammation. Modulation by autoantibodies and fever (1992) (2)
- Possible correlation of TNF alpha-production with -RFLP in humans. (1989) (2)
- Effects of Cyclic GMP‐Agonists on Ciclosporin‐Induced Suppression of Human Lymphokine Production (1985) (2)
- Sa1236 Antibodies Against Infliximab Are Associated With Increased Risk of Anti-Adalimumab Antibody Development in Patients With Inflammatory Bowel Disease (2014) (2)
- A1174 IMMUNOLOGICAL AND HORMONAL RESPONSES TO LUNG SURGERY DURING ONE-LUNG VENTILATION (1990) (2)
- Decreased short-term production of tumor necrosis factor-alpha and interleukin-1beta in human immunodeficiency virus-seropositive subjects. (1997) (2)
- W1270 Discriminating Between Response Types in Infliximab-Treated Patients With Crohn's Disease: Sensitivity and Specificity of Combined Assessment of Infliximab Trough Levels and Anti-Drug Antibodies (2010) (2)
- Case Study: Immunogenicity of Interferon-Beta (2008) (2)
- Tu1142 Secondary Infliximab Treatment Failure in Crohn's Disease: Therapeutic Implications of Measuring Drug and Anti-Drug Antibodies by Three Different Binding Assays (2013) (2)
- P374 Secondary infliximab treatment failure in Crohn's disease: therapeutic implications of measuring drug and anti-drug antibodies by three different binding assays (2013) (2)
- Eosinophil cationic protein and eosinophil protein X: human amniotic fluid concentrations and gestational tissue content at term. (1998) (2)
- [The role of cell adhesion molecules in inflammatory bowel disease and colorectal cancer]. (1997) (2)
- [Cyclosporin A. A different immunosuppressive agent]. (1983) (2)
- Tissue culture supernatants from human islets of Langerhans activate the oxidative burst response of human monocytes in vitro. (1995) (2)
- [Danger signals and inflammasomes in autoinflammatory and autoimmune diseases]. (2011) (2)
- An Unusual Case of Multiple Malignancy in an Adult (1984) (2)
- [Monitoring of bioavailability, pharmacokinetics and immunogenicity of tumour necrosis factor-alpha inhibitors]. (2010) (2)
- CYTOKINES IN PLASMA AND ULTRAFILTRATE IN RELATION TO HEMOFILTRATION (1991) (2)
- 40 – CYTOKINE ANTIBODIES (2007) (1)
- Lack of Evidence for Human Lymphokines with Thrombocyte Aggregating Activity (1984) (1)
- Comparison of Techniques for Monitoring Infliximab and Antibodies to Infliximab in Crohnʼs Disease Patients with Infliximab Treatment Failure: 1546 (2012) (1)
- Low prevalence of antibodies and other plasma factors binding to CC chemokines and IL‐2 in HIV‐positive patients (2000) (1)
- [Gingival hyperplasia due to treatment with cyclosporin (cyclosporin A)]. (1984) (1)
- Necrotic ulceration of the nose in a patient with primary immunodeficiency syndrome characterized by severe defects in the production of cytokines. (1993) (1)
- Interleukin‐6 (IL‐6) is not removed from plasma during experimental haemofiltration (1998) (1)
- P558 Antibodies against infliximab are associated with increased risk of anti-adalimumab antibody development in patients with inflammatory bowel disease (2014) (1)
- Anti-TNF-α Therapy for Extraintestinal Manifestations of Inflammatory Bowel Disease (2015) (1)
- Morphological effects of sodium fusidate (fusidin) on pancreatic islet cells: an electron microscopic study. (1994) (1)
- [Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study]. (1990) (1)
- A role of immunoinflammatory hormones (cytokines) in insulin dependent diabetes mellitus? (1990) (1)
- The Influence of Interleukin-1 on The Function of Human Thyroid Cells (1987) (1)
- [Leukocyte migration inhibitory factor (LIF). From biological test to biochemical characterization of this lymphokine]. (1979) (1)
- [Biopharmaceuticals in the treatment of rheumatoid arthritis]. (2008) (1)
- [Autoinflammatory disease: a new concept]. (2002) (1)
- [Innate immunity, autoimmunity and autoinflammation]. (2011) (1)
- Neutralising antibodies against interferon beta in multiple sclerosis (2004) (1)
- No Development of Neutralizing Antibodies Against Recombinant Interferon-Alpha in Ph-Negative Myeloproliferative Neoplasms: A prospective Study (2015) (1)
- Immunohistology of Skin from AIDS Patients (1991) (1)
- Induction of Antigen‐Specific Immunological Unresponsiveness by Inhibitors of Human Lymphocyte‐Activating Factor (1981) (1)
- [Problems with clinical use of recombinant proteins]. (2003) (1)
- Diagnosis of Hodgkin's disease hampered by an Epstein-Barr virus infection treated with acyclovir. (2009) (1)
- Modulation of Inflammatory Cytokines by a Receptor Antagonist, Autoantibodies, and Fever (1993) (1)
- [Apoptosis--programmed cell death]. (1999) (1)
- Prevention and Treatment of Lethal Murine Endotoxemia by the Novel Immunomodulatory Agent MFP-14 (2001) (1)
- Inhibitor of interleukin-1α and interleukin-1β-induced T-cell activation in serum of patients with active Crohn's disease (1991) (1)
- [Adalimumab in the treatment of rheumatoid arthritis]. (2004) (1)
- Section Review Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Experimental cytokine modulation therapy of inflammatory bowel disease (Crohn's disease and ulcerative colitis) (1996) (1)
- [Immunogenicity of biopharmaceuticals. Experiences with beta-interferon, EPO and anti-TNF]. (2003) (1)
- Inhibitor of interleukin-1 alpha and interleukin-1 beta-induced T-cell activation in serum of patients with active Crohn's disease. (1991) (1)
- Lymphokines That Affect the Migration of Polymorphonuclear Leukocytes (1981) (1)
- Antibodies to interleukin-6 in sera from normal individuals and patients with immunoinflammatory disorders (1991) (0)
- Corrigendum (2008) (0)
- Human somatotrophic (GH) adenoma cells interleukin (IL)-1 β induces production of il-6 and il-8. (2007) (0)
- P643 Therapeutic thresholds for infliximab trough levels during maintenance treatment in patients with inflammatory bowel disease. (2017) (0)
- The Role of Immune Complexes Consisting of Myelin Basic Protein (MBP), Anti‐MBP Antibodies and Complement in Promoting CD4+ T‐cell Responses to MBP in Health and Multiple Sclerosis (2004) (0)
- Increased Concentrations ofInterleukin-6 andInterleukin-1 Receptor Antagonist andDecreased Concentrations ofBeta-2-Glycoprotein I inGambianChildren withCerebral Malaria (1994) (0)
- Three suggestions for involvement of immunoinflammatory peptides (cytokines) in the pathogenesis of multiple sclerosis (1992) (0)
- Interleukin 10 Induces the Maturation of Putative Tolerogenic Monocyte-derived Dendritic Cells as Revealed by GeneArray Analysis (2005) (0)
- Abnormal vitamin D3metabolism inpatients with primary Sjogren's syndrome (1990) (0)
- [Sclersong peritonitis during practolol (Eraldine) therapy]. (1975) (0)
- [DNA microchips: after a revolution in biotechnology with great clinical and scientific possibilities]. (1998) (0)
- Interleukin 6: A Pathogenic Factor in Autoimmune Thyroid Diseases? (1991) (0)
- Clinical significance of antibodies to interferon beta therapy in patients with relapsing–remitting multiple sclerosis (2009) (0)
- Monitoring Patients Treated with Type1 Interferons: Potential Reporter Genes in Patient Leucocytes (2004) (0)
- Therapy-induced antibodies against interferon-β-1a and interferon-β-1b in patients with multiple sclerosis (2001) (0)
- [New biological drugs for the treatment of chronic inflammatory diseases]. (2008) (0)
- P584 A role for therapeutic drug-monitoring during infliximab induction treatment in inflammatory bowel disease? (2017) (0)
- 742 DISCONTINUATION OF INFLIXIMAB THERAPY IN PATIENTS WITH CROHN'S DISEASE IN SUSTAINED, COMPLETE CLINICAL-BIOCHEMICAL-ENDOSCOPIC REMISSION: A DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL (2021) (0)
- Effects ofsodiumfusidate inanimal modelsofinsulin-dependent diabetes mellitus andseptic shock (1995) (0)
- Regulation of the Immune Response (1983) (0)
- Inhibition of human leukocyte migration inhibitory factor (LIF) by alpha-L-fucose. (1975) (0)
- DRUG EFFECTS ON HUMAN LEUCOCYTE MIGRATION AND MIGRATION INHIBITORY ACTIVITY FROM LYMPHOCYTES STIMULATED WITH CONCANAVALIN A (2009) (0)
- [Cell-mediated hypersensitivity and lymphokines]. (1976) (0)
- [Molecular biology and inflammation]. (1995) (0)
- Fusidin down-regulates the production of IL-6 in septic patients: a pilot study (2000) (0)
- Sa1786 - Plasma Cytokine Profiles in IBD Primary Non-Responders Versus Responders to Infliximab (2018) (0)
- Selected abstracts from allergy (2004) (0)
- Biochemical characterization of the human lymphokine leukocyte migration inhibitory factor (LIF): role of cGMP as a specific inhibitor of the LIF esterase activity. (1979) (0)
- [Molecular biology and rheumatology]. (1995) (0)
- [Fever and acute phase reaction as a link in the cytokine-mediated cellular language]. (1991) (0)
- Sa1268 Individualized Therapy Is Long-Term Cost-Effective Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab (2015) (0)
- [The tower of Babel of terminology concerning lymphokines and interleukins (cytokines)]. (1989) (0)
- Interleukin 1β - an unstable monomer (1991) (0)
- Interleukin 6 is a modulator of beta-cell function (1990) (0)
- Demonstration of myelin basic protein-reactive antibodies in healthy individuals and patients with multiple sclerosis using a novel highly sensitive assay (2009) (0)
- Modulation of IgE-mediated basophil histamine release by various cytokines. (1992) (0)
- [Toll-like receptors. What can we learn about the immune system from banana flies and a mouse strain]. (2001) (0)
- Immunogenicitet af biologiske laegemidler. Erfaringer med betainterferon, EPO og anti-TNF (2003) (0)
- FRI0031 Naturally occurring antibodies against different IFN-alpha subtypes are observed in some SLE patients, and may impact the IFN gene signature and disease activity (2013) (0)
- Failure to detect cytokines in CSF of patients with optic neuritis and multiple sclerosis (1991) (0)
- Interleukin-6 is an endogenous modulator of b-cell structure and function (1989) (0)
- Selected abstracts from allergy (2004) (0)
- Are microbiomes involved in paroxysmal atrial fibrillation? Repeated clinical improvement after pivmecillinam (amdinocillin) therapy (2021) (0)
- [Biological drugs in the treatment of immunoinflammatory diseases]. (2008) (0)
- Lewis and AB0 blood group-phenotypes in periodontitis, cardiovascular disease, obesity and stroke (2019) (0)
- Increase in myocardial capillary permeability by tumor necrosis factor alpha (TNF) (1992) (0)
- Monitoring Patients Treated with Type 1 Interferons: Antiviral versus MxA Induction Assays (2004) (0)
- Gene chip analysis of gastric gene expression in gastrin-deficient mice (2001) (0)
- Letter to the Editor (1999) (0)
- Ciclosporin (CyA) in the Management of Polymyositis/Idiopathic Cardiomyopathy (1985) (0)
- Single nucleotide polymorphisms in genes encoding toll-like receptors 7, 8 and 9 in Danish patients with systemic lupus erythematosus (2014) (0)
- 12 Pre-existing IgG antibodies to the Fab region of infliximab predict efficacy and safety in IBD patients naive to anti-TNF agents (2013) (0)
- Expression of an Insulin/lnterleukin-I Receptor Antagonist Hybrid Gene in Insulin-producing Cell Lines (HIT-T15 and NIT-1) Confers Resistance against Interleukin-1 -induced Nitric Oxide Production (2013) (0)
- DIAGNOSIS, TREATMENT AND PREVENTION OF VASCULAR DISEASES USING IL-1alpha autoantibodies (2006) (0)
- Commentary: antibodies reacting with the infliximab Fab portion – something new? Authors' reply (2013) (0)
- The Effects of Interleukin-1 (cid:98) (IL-1 (cid:98) ) on Human Thyrocyte Functions Are Counteracted by the IL-1 Receptor Antagonist* (1997) (0)
- [Biological response modifiers in the treatment of immunoinflammatory diseases]. (2008) (0)
- Induction of antigenspecific T cell unresponsiveness by drugs known to inactivate the monokine, T cell-activating factor (TAF) (1982) (0)
- Treatment of myocarditis and polymyositic heart disease guided by endomyocardial biopsy. (1989) (0)
- Circulating igm antibodies against myelin basic protein in health and multiple sclerosis: A possible component in the regulation of self-reactivity? (2007) (0)
- [Treatment of rheumatoid arthritis with anti-TNF antibodies]. (1995) (0)
- Sa1243 Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease (2014) (0)
- Polymorphonuclear degranulation complement activation and the cytokine response in lung cancer patients undergoing thoracotomy (1994) (0)
- Cyklosporin a and methylprednisolone suppress antigen-induced lymphokine production at distinct sites of the macrophage-T cell cooperative processes (1982) (0)
- Pathophysiological assessment--macrophages. (1983) (0)
- Infusion of hypertonic saline before elective laparotomy. Effects on cytokines and hormones (2005) (0)
- [The macrophage hormone interleukin 1 (IL-1) and the tumor necrosis factor. Biological and physiopathological significance]. (1987) (0)
- Endotoxins Do not Mimick the Effect of Interleukin-1 in Secondary Cultures of Human Thyroid Cells (1991) (0)
- of neutralizing antibodies in multiple sclerosis patients Polymorphisms of innate pattern recognition receptors , response to interferon-beta and development (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Klaus Bendtzen?
Klaus Bendtzen is affiliated with the following schools: